In RA patients, lysosomes are overactive in inflammatory cells, showing increased levels of CtsB, CtsD, CtsG, CtsK, CtsL, and CtsS that contribute to most of the clinical manifestations of RA [127,128,132,133,134,135,136,137,138,139]. This evidence concerns the gene CTSK and rheumatoid arthritis.